CYP2D6 and ABCB1 genetic variability: influence on paroxetine plasma level and therapeutic response
Published inTherapeutic drug monitoring, vol. 30, no. 4, p. 474-482
Publication date2008
Abstract
Keywords
- Adolescent
- Adult
- Aged
- Algorithms
- Analysis of Variance
- Antidepressive Agents, Second-Generation/blood/therapeutic use
- Cytochrome P-450 CYP2D6/genetics
- Depressive Disorder, Major/blood/drug therapy
- Female
- Gas Chromatography-Mass Spectrometry
- Genetic Variation
- Humans
- Linear Models
- Male
- Middle Aged
- P-Glycoprotein/genetics
- Paroxetine/blood/therapeutic use
- Phenotype
- Psychiatric Status Rating Scales
- Young Adult
Citation (ISO format)
GEX-FABRY, Marianne et al. CYP2D6 and ABCB1 genetic variability: influence on paroxetine plasma level and therapeutic response. In: Therapeutic drug monitoring, 2008, vol. 30, n° 4, p. 474–482. doi: 10.1097/FTD.0b013e31817d6f5d
Main files (1)
Article (Accepted version)

Identifiers
- PID : unige:1215
- DOI : 10.1097/FTD.0b013e31817d6f5d
- PMID : 18641553
ISSN of the journal0163-4356